Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AMLX

Amylyx Pharmaceuticals Inc

May 29 • 04:00PM ET

14.35

+0.13 0.91 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Small • NASD

Peers: INDV ALKS KNSA LNTH TLX NBIX BMRN AXSM INCY VRTX

| Held by: VTI IWM VXF IBB IWO VTWO XPH SCHA DFMC IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.51	Insider Own	16.71%	Shs Outstand	111.03M	Perf Week	3.02%
Market Cap	1.60B	Forward P/E	-	EPS next Y	-1.27	Insider Trans	-2.16%	Shs Float	92.60M	Perf Month	-8.01%
Enterprise Value	1.32B	PEG	-	EPS next Q	-0.35	Inst Own	96.19%	Short Float	15.67%	Perf Quarter	-5.41%
Income	-150.11M	P/S	-	EPS this Y	7.86%	Inst Trans	1.15%	Short Ratio	13.21	Perf Half Y	-3.56%
Sales	0.00M	P/B	5.83	EPS next Y	9.85%	ROA	-58.49%	Short Interest	14.51M	Perf YTD	18.79%
Book/sh	2.46	P/C	5.70	EPS next 5Y	27.97%	ROE	-63.26%	52W High	18.60 -22.87%	Perf Year	192.86%
Cash/sh	2.52	P/FCF	-	EPS past 3/5Y	19.94% -15.37%	ROIC	-54.07%	52W Low	4.70 204.99%	Perf 3Y	-42.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	3.46% 5.01%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	51.42%	Oper. Margin	-	ATR (14)	0.72	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.85	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	47.06	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	17.85	EPS Q/Q	10.88%	SMA20	-0.69%	Beta	-0.16	Target Price	23.40
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	-5.84%	Rel Volume	0.77	Prev Close	14.22
Employees	136	LT Debt/Eq	0.02	Earnings	May 07 BMO	SMA200	4.90%	Avg Volume	1.10M	Price	14.35
IPO	Jan 07, 2022	Option/Short	Yes / Yes	EPS/Sales Surpr.	-9.50% -	Trades		Volume	842,412	Change	0.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)